Kintiga
- Financial, legal, consulting
Kintiga (formerly MAP Patient Access, AxTalis & SKC) is Europe’s largest independent specialist pharmaceutical and biotechnology management consultancy. Its unique capabilities enable companies to maximise the value of their product portfolios, while providing patients with life-changing health solutions, by facilitating access to medicines across Europe’s complex medical, regulatory and payer environment.
Kintiga provides a unique combination of specialist consultancy products and services across the development path to commercialisation, along with an online membership platform providing uninterrupted access to experts as well as an extensive and unique database, set of tools and invaluable content, to a wide range of pharmaceutical and biotech companies across Europe.
Kintiga is headquartered in the United Kingdom, with additional sites across Europe, providing its range of products and services to customers across the globe, and backed by Kester Capital.